# Manitowoc Co Inc: financial statements, quarterly

MTW · NYSE · CIK 61986 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtw.md) · [Financials](/companies/mtw/financials.md) · [Filings](/companies/mtw/filings.md) · [Insiders](/companies/mtw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [521](/filings/0000950170-24-119534.md) | [596 d](/filings/0001193125-26-057356.md) | [495](/filings/0000950170-25-065630.md) | [562](/filings/0000950170-25-105838.md) | [525](/filings/0001193125-25-270010.md) | [596 d](/filings/0001193125-26-057356.md) | [471](/filings/0001193125-26-209106.md) | [540](/filings/0001193125-26-340218.md) | [553](/filings/0001193125-25-270010.md) | [677 d](/filings/0001193125-26-057356.md) | [495](/filings/0001193125-26-209106.md) | [595](/filings/0001193125-26-340218.md) |
| Cost of revenue | $m | [424](/filings/0000950170-24-119534.md) | [497 d](/filings/0001193125-26-057356.md) | [403](/filings/0000950170-25-065630.md) | [462](/filings/0000950170-25-105838.md) | [437](/filings/0001193125-25-270010.md) | [501 d](/filings/0001193125-26-057356.md) | [381](/filings/0001193125-26-209106.md) | [441](/filings/0001193125-26-340218.md) | [451](/filings/0001193125-25-270010.md) | [564 d](/filings/0001193125-26-057356.md) | [399](/filings/0001193125-26-209106.md) | [472](/filings/0001193125-26-340218.md) |
| Gross profit | $m | [96.8](/filings/0000950170-24-119534.md) | [99.1 d](/filings/0001193125-26-057356.md) | [92.5](/filings/0000950170-25-065630.md) | [99.7](/filings/0000950170-25-105838.md) | [87.6](/filings/0001193125-25-270010.md) | [95.2 d](/filings/0001193125-26-057356.md) | [89.8](/filings/0001193125-26-209106.md) | [99.0](/filings/0001193125-26-340218.md) | [103](/filings/0001193125-25-270010.md) | [113 d](/filings/0001193125-26-057356.md) | [95.3](/filings/0001193125-26-209106.md) | [123](/filings/0001193125-26-340218.md) |
| Operating income | $m | [18.0](/filings/0000950170-24-119534.md) | [9.8 d](/filings/0001193125-26-057356.md) | [15.2](/filings/0000950170-25-065630.md) | [12.9](/filings/0000950170-25-105838.md) | [7.5](/filings/0001193125-25-270010.md) | [16.2 d](/filings/0001193125-26-057356.md) | [5.3](/filings/0001193125-26-209106.md) | [9.8](/filings/0001193125-26-340218.md) | [18.5](/filings/0001193125-25-270010.md) | [20.2 d](/filings/0001193125-26-057356.md) | [3.1](/filings/0001193125-26-209106.md) | [31.1](/filings/0001193125-26-340218.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0000950170-24-119534.md) | [6.0 d](/filings/0001193125-26-057356.md) | [1.9](/filings/0000950170-25-065630.md) | [1.6](/filings/0000950170-25-105838.md) | [(0.3)](/filings/0001193125-25-270010.md) | [(47.3) d](/filings/0001193125-26-057356.md) | [(2.5)](/filings/0001193125-26-209106.md) | [(0.2)](/filings/0001193125-26-340218.md) | [2.5](/filings/0001193125-25-270010.md) | [5.4 d](/filings/0001193125-26-057356.md) | [(3.3)](/filings/0001193125-26-209106.md) | [7.2](/filings/0001193125-26-340218.md) |
| Net income | $m | [10.4](/filings/0000950170-24-119534.md) | [(7.9) d](/filings/0001193125-26-057356.md) | [4.5](/filings/0000950170-25-065630.md) | [1.6](/filings/0000950170-25-105838.md) | [(7.0)](/filings/0001193125-25-270010.md) | [56.7 d](/filings/0001193125-26-057356.md) | [(6.3)](/filings/0001193125-26-209106.md) | [1.5](/filings/0001193125-26-340218.md) | [5.0](/filings/0001193125-25-270010.md) | [7.0 d](/filings/0001193125-26-057356.md) | [(6.0)](/filings/0001193125-26-209106.md) | [14.2](/filings/0001193125-26-340218.md) |
| Diluted EPS | $ per share | [0.29](/filings/0000950170-24-119534.md) | not reported | [0.12](/filings/0000950170-25-065630.md) | [0.04](/filings/0000950170-25-105838.md) | [(0.20)](/filings/0001193125-25-270010.md) | not reported | [(0.18)](/filings/0001193125-26-209106.md) | [0.04](/filings/0001193125-26-340218.md) | [0.14](/filings/0001193125-25-270010.md) | not reported | [(0.17)](/filings/0001193125-26-209106.md) | [0.39](/filings/0001193125-26-340218.md) |
| Basic EPS | $ per share | [0.30](/filings/0000950170-24-119534.md) | not reported | [0.13](/filings/0000950170-25-065630.md) | [0.05](/filings/0000950170-25-105838.md) | [(0.20)](/filings/0001193125-25-270010.md) | not reported | [(0.18)](/filings/0001193125-26-209106.md) | [0.04](/filings/0001193125-26-340218.md) | [0.14](/filings/0001193125-25-270010.md) | not reported | [(0.17)](/filings/0001193125-26-209106.md) | [0.39](/filings/0001193125-26-340218.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [40.0](/filings/0000950170-23-058333.md) | [34.4](/filings/0000950170-25-024838.md) | [31.5](/filings/0000950170-24-055669.md) | [38.1](/filings/0000950170-24-094032.md) | [22.9](/filings/0000950170-24-119534.md) | [48.0](/filings/0001193125-26-057356.md) | [41.4](/filings/0000950170-25-065630.md) | [32.9](/filings/0000950170-25-105838.md) | [39.7](/filings/0001193125-25-270010.md) | [77.3](/filings/0001193125-26-340218.md) | [78.4](/filings/0001193125-26-209106.md) | [95.8](/filings/0001193125-26-340218.md) |
| Current assets | $m | [1,053](/filings/0000950170-23-058333.md) | [1,033](/filings/0000950170-25-024838.md) | [1,119](/filings/0000950170-24-055669.md) | [1,093](/filings/0000950170-24-094032.md) | [1,104](/filings/0000950170-24-119534.md) | [959](/filings/0001193125-26-057356.md) | [1,055](/filings/0000950170-25-065630.md) | [1,163](/filings/0000950170-25-105838.md) | [1,182](/filings/0001193125-25-270010.md) | [1,097](/filings/0001193125-26-340218.md) | [1,133](/filings/0001193125-26-209106.md) | [1,217](/filings/0001193125-26-340218.md) |
| Total assets | $m | [1,692](/filings/0000950170-23-058333.md) | [1,707](/filings/0000950170-25-024838.md) | [1,781](/filings/0000950170-24-055669.md) | [1,748](/filings/0000950170-24-094032.md) | [1,777](/filings/0000950170-24-119534.md) | [1,660](/filings/0001193125-26-057356.md) | [1,764](/filings/0000950170-25-065630.md) | [1,884](/filings/0000950170-25-105838.md) | [1,901](/filings/0001193125-25-270010.md) | [1,818](/filings/0001193125-26-340218.md) | [1,843](/filings/0001193125-26-209106.md) | [1,922](/filings/0001193125-26-340218.md) |
| Current liabilities | $m | [589](/filings/0000950170-23-058333.md) | [563](/filings/0000950170-25-024838.md) | [632](/filings/0000950170-24-055669.md) | [579](/filings/0000950170-24-094032.md) | [561](/filings/0000950170-24-119534.md) | [474](/filings/0001193125-26-057356.md) | [555](/filings/0000950170-25-065630.md) | [560](/filings/0000950170-25-105838.md) | [552](/filings/0001193125-25-270010.md) | [492](/filings/0001193125-26-340218.md) | [540](/filings/0001193125-26-209106.md) | [577](/filings/0001193125-26-340218.md) |
| Long-term debt | $m | not reported | [374](/filings/0000950170-24-019452.md) | not reported | not reported | not reported | [395](/filings/0000950170-25-024838.md) | not reported | not reported | not reported | [465](/filings/0001193125-26-057356.md) | not reported | not reported |
| Current portion of debt | $m | [30.3](/filings/0000950170-23-058333.md) | [13.4](/filings/0000950170-25-024838.md) | [42.5](/filings/0000950170-24-055669.md) | [21.4](/filings/0000950170-24-094032.md) | [40.5](/filings/0000950170-24-119534.md) | [13.1](/filings/0001193125-26-057356.md) | [17.6](/filings/0000950170-25-065630.md) | [10.7](/filings/0000950170-25-105838.md) | [20.5](/filings/0001193125-25-270010.md) | [13.7](/filings/0001193125-26-340218.md) | [10.8](/filings/0001193125-26-209106.md) | [8.9](/filings/0001193125-26-340218.md) |
| Shareholders' equity | $m | [573](/filings/0000950170-23-058333.md) | [603](/filings/0000950170-25-024838.md) | [596](/filings/0000950170-24-055669.md) | [592](/filings/0000950170-24-094032.md) | [608](/filings/0000950170-24-119534.md) | [640](/filings/0001193125-26-057356.md) | [652](/filings/0000950170-25-065630.md) | [681](/filings/0000950170-25-105838.md) | [683](/filings/0001193125-25-270010.md) | [695](/filings/0001193125-26-340218.md) | [686](/filings/0001193125-26-209106.md) | [701](/filings/0001193125-26-340218.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.3 d](/filings/0000950170-24-119534.md) | [39.8 d](/filings/0001193125-26-057356.md) | [(30.6)](/filings/0000950170-25-065630.md) | [11.0 d](/filings/0000950170-25-105838.md) | [(43.6) d](/filings/0001193125-25-270010.md) | [112 d](/filings/0001193125-26-057356.md) | [12.9](/filings/0001193125-26-209106.md) | [(67.7) d](/filings/0001193125-26-340218.md) | [(14.1) d](/filings/0001193125-25-270010.md) | [91.1 d](/filings/0001193125-26-057356.md) | [27.4](/filings/0001193125-26-209106.md) | [8.0 d](/filings/0001193125-26-340218.md) |
| Capital expenditure | $m | [23.6](/filings/0000950170-23-058333.md) | [17.5 d](/filings/0001193125-26-057356.md) | [12.2](/filings/0000950170-25-065630.md) | [12.9 d](/filings/0000950170-25-105838.md) | [9.3 d](/filings/0001193125-25-270010.md) | [11.3 d](/filings/0001193125-26-057356.md) | [10.8](/filings/0001193125-26-209106.md) | [6.0 d](/filings/0001193125-26-340218.md) | [7.9 d](/filings/0001193125-25-270010.md) | [12.8 d](/filings/0001193125-26-057356.md) | [8.2](/filings/0001193125-26-209106.md) | [14.1 d](/filings/0001193125-26-340218.md) |
| Dividends paid | $m | [0.0](/filings/0000950170-24-119534.md) | [0.0 d](/filings/0001193125-26-057356.md) | [0.0](/filings/0000950170-25-065630.md) | [0.0](/filings/0000950170-25-105838.md) | [0.0](/filings/0001193125-25-270010.md) | [0.0 d](/filings/0001193125-26-057356.md) | [0.0](/filings/0001193125-26-209106.md) | [0.0](/filings/0001193125-26-340218.md) | [0.0](/filings/0001193125-25-270010.md) | [0.0 d](/filings/0001193125-26-057356.md) | [0.0](/filings/0001193125-26-209106.md) | [0.0](/filings/0001193125-26-340218.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-119534.md) | [0.0 d](/filings/0001193125-26-057356.md) | [0.0](/filings/0000950170-24-055669.md) | [5.7 d](/filings/0000950170-25-105838.md) | [0.0 d](/filings/0001193125-25-270010.md) | [0.0 d](/filings/0001193125-26-057356.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-270010.md) | [0.0 d](/filings/0001193125-26-057356.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.4](/filings/0000950170-23-058333.md) | [35.3](/filings/0000950170-25-065630.md) | [35.7](/filings/0000950170-24-094032.md) | [35.8](/filings/0000950170-24-119534.md) | [36.1](/filings/0000950170-25-065630.md) | [35.7](/filings/0000950170-25-105838.md) | [35.1](/filings/0001193125-25-270010.md) | [35.3](/filings/0001193125-26-209106.md) | [35.8](/filings/0001193125-26-340218.md) | [36.3](/filings/0001193125-25-270010.md) | [35.7](/filings/0001193125-26-209106.md) | [36.5](/filings/0001193125-26-340218.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,061,969 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340218.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.